Delivery Order SPE2DB20D2001-SPE2DB23FM61E
Award Date
6/28/23
Potential Completion Date
6/29/23
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,614.18 firm fixed-price contract is for the delivery of Uroxatral 10 mg tablets, a medication used to treat symptoms of an enlarged prostate. The contract has an ultimate completion date of November 3, 2022 and was awarded on November 2, 2022. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under a Delivery Order contract. The contract is for the supply of Uroxatral 10 mg tablets, a medication used to treat an enlarged prostate. The contract has a firm fixed price of $29,123.27 and an ultimate completion date of May 12, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Uroxatral 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The contract has a ceiling value of $17,717.97 and a completion date of September 14, 2023. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $20,208.61 firm fixed-price contract is for the delivery of UROXATRAL 10 MG TABLET 100S, a medication used to treat symptoms of an enlarged prostate. The contract has an ultimate completion date of August 17, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Uroxatral 10 mg tablets. The contract, valued at $22,588.35, is a firm fixed-price delivery order awarded without any set-aside requirements. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,363.70, is for the delivery of Uroxatral 10 mg tablets, a medication used to treat benign prostatic hyperplasia. This is a Firm Fixed Price Delivery Order contract with a completion date of December 1, 2022. The contract does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Uroxatral 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The contract has a ceiling value of $27,272.45 and a period of performance through October 18, 2023. It is a firm-fixed-price contract and was not set aside for any specific business classification....
This federal contract award, valued at $41,212.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order contract is for the procurement of Uroxatral 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The contract has a period of performance through February 20, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant Indefinite...
This federal contract award is for the delivery of Uroxatral 10 mg tablets in quantities of 100 to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $12,658.40 and an ultimate completion date of December 28, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Uroxatral 10 mg tablets. The $11,916.73 award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside...